首页> 美国卫生研究院文献>Biochemical Journal >Copper inhibits beta-amyloid production and stimulates the non-amyloidogenic pathway of amyloid-precursor-protein secretion.
【2h】

Copper inhibits beta-amyloid production and stimulates the non-amyloidogenic pathway of amyloid-precursor-protein secretion.

机译:铜抑制β-淀粉样蛋白的产生并刺激淀粉样前体蛋白分泌的非淀粉样生成途径。

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Previous studies have demonstrated that amyloid precursor protein (APP) can bind and reduce Cu(II) to Cu(I), leading to oxidative modification of APP. In the present study we show that adding copper to Chinese-hamster ovary (CHO) cells greatly reduced the levels of amyloid Abeta peptide (Abeta) both in parental CHO-K1 and in copper-resistant CHO-CUR3 cells, which have lower intracellular copper levels. Copper also caused an increase in the secretion of the APP ectodomain, indicating that the large decrease in Abeta release was not due to a general inhibition in protein secretion. There was an increase in intracellular full-length APP levels which paralleled the decrease in Abeta generation, suggesting the existence of two distinct regulating mechanisms, one acting on Abeta production and the other on APP synthesis. Maximal inhibition of Abeta production and stimulation of APP secretion was achieved in CHO-K1 cells at about 10 microM copper and in CHO-CUR3 cells at about 50 microM copper. This dose 'window of opportunity' at which copper promoted the non-amyloidogenic pathway of APP was confirmed by an increase in the non-amyloidogenic p3 fragment produced by alpha-secretase cleavage. Our findings suggest that copper or copper agonists might be useful tools to discover novel targets for anti-Alzheimer drugs and may prove beneficial for the prevention of Alzheimer's disease.
机译:先前的研究表明淀粉样蛋白前体蛋白(APP)可以结合并还原Cu(II)到Cu(I),从而导致APP的氧化修饰。在本研究中,我们表明,将铜添加到中国仓鼠卵巢(CHO)细胞中可大大降低亲本CHO-K1和铜耐药的CHO-CUR3细胞中淀粉样蛋白Abeta肽(Abeta)的水平,这些细胞的细胞内铜含量较低水平。铜还导致APP胞外域的分泌增加,表明Abeta释放的大幅下降并非由于蛋白质分泌的普遍抑制。细胞内全长APP水平的增加与Abeta产生的减少平行,表明存在两种不同的调节机制,一种作用于Abeta产生,另一种作用于APP合成。在约10 microM铜的CHO-K1细胞中和在约50 microM铜的CHO-CUR3细胞中实现了对Abeta产生的最大抑制和APP分泌​​的刺激。铜促进APP非淀粉样生成途径的剂量“机会之窗”通过α-分泌酶裂解产生的非淀粉样生成p3片段的增加得到证实。我们的发现表明,铜或铜激动剂可能是发现抗阿尔茨海默病药物新靶标的有用工具,并且可能被证明对预防阿尔茨海默氏病有益。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号